Search

Author/Creator Ortiz-Romero, PL

1. Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: data from the Spanish Primary Cutaneous Lymphoma Registry. (September 2022)

Authors:
Muniesa, C; Gallardo, F; García-Doval, I; Estrach, MT; Combalia, A; Morillo-Andújar, M; De la Cruz Vicente, F; Machan, S; Moya-Martínez, C; Rovira, R; Sanchez-Gonzalez, B; Acebo, E; Amutio, E; Peñate, Y; Losada-Castillo, MC; García-Muret, MP; Iznardo, H; Román-Curto, C; Cañueto, J; de Misa, R Fer...
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Final report of PIMTO-MF clinical trial: multicenter, phase II trial for treatment of early MF with topical pimecrolimus. (September 2022)

Authors:
Ortiz-Romero, PL; Jiménez, L Maroñas; Muniesa, C; Estrach, T; Servitje, O; de Misa, R Fernández; Gallardo, F; Martín, O San; Riveiro-Falkenbach, E; Díaz, N García; Vega, R; Lora, D; Postigo, C; Jiménez, B; Sánchez-Beato, M; Vaqué, JP; Peralto, JL Rodríguez; de la Cámara, A Gómez; De la Cruz, J; P...
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Immunophenotypic identification and characterization of CTCL tumor cells in blood using standardized flow cytometry: a European multicenter study. (September 2022)

Authors:
Najidh, S; Van der Sluijs Gelling, AJ; Cozzio, A; Dobos, G; Bagot, M; Beylot-Barry, M; Guenova, E; Nicolay, J; Lima, M; Ortiz-Romero, PL; Papadavid, E; Pujol, R; Quaglino, P; Stadler, R; Wehkamp, U; Whittaker, S; Van Dongen, JJM; Montero, J Flores; Almeida, J; Vermeer, MH
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Intralesional brentuximab vedotin: our experience in the treatment of CD30+ primary cutaneous T-cell lymphomas. (September 2022)

Authors:
Andrés, JA Arroyo; Muñiz, CA Rubio; De Dios, MA Agud; López, D Falkenhain; Mitsunaga, K; Velázquez, A Sánchez; Llorente, C Postigo; Ortiz-Romero, PL
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial. (September 2022)

Authors:
Bagot, M; Muller, M; Kim, YH; Ortiz-Romero, PL; Zinzani, PL; Beylot-Barry, M; Dalle, S; Jacobsen, E; Combalia, A; Huen, A; Mehta-Shah, N; Khodadoust, MS; Viotti, J; Paiva, C; Porcu, P
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. (September 2022)

Authors:
Muniz, CA Rubio; Vicente, EJ Tarín; Andrés, JA Arroyo; De Dios, MA Agud; Alonso, C Vico; Velázquez, A Sánchez; Llorente, C Postigo; Ortiz-Romero, PL
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Mycosis fungoides: molecular identity revealed by nanostring analysis. (September 2022)

Authors:
Alonso, R Alonso; Moreno, M Rodríguez; Díaz, N García; García, JF García; Roca, LT; Caselles, J Borregón; Rodríguez, M Cabezuelo; Company, L Cereceda; Pinilla, SM Rodríguez; Mascuñano, R Córdoba; Castro, J Torre; Álvarez, CM García; Peralto, JL Rodríguez; Díaz, R Rivera; Díez, JP Vaqué; Ortiz-Rom...
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Real-world study of the use of pegylated interferon alfa for treatment of primary cutaneous T-cell lymphomas: an EORTC CLTF study. (September 2022)

Authors:
Mitsunaga, K; Bagot, M; Beylot-Barry, M; Ram-Wolff, C; Guenova, E; Fassnacht, C; Hodak, E; Amitay, I; Papadavid, E; Jonak, C; Porkert, S; Scarisbrick, J; Applewaite, R; Nicolay, J; Quaglino, P; Sanches Jr, J; Martins, J Cury; Ortiz-Romero, PL
Journal:
European journal of cancer
Issue:
Volume 173(2022)Supplement 1
Page Start:
S24
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search